Should you buy, sell or hold IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life shares?
Which stocks to buy, hold or sell today? As Dalal Street enters the April 25 session, here's a look at what brokerages make of some of the key stocks that are trending today. Stocks such as IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life Insurance, Apollo Hospitals, Macrotech Developers, and other shares are on their radar today.
Which stocks to buy, hold or sell today? As Dalal Street enters the April 25 session, here's a look at what brokerages make of some of the key stocks that are in focus.
Stocks such as IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life Insurance, Apollo Hospitals, Macrotech Developers, and other shares are on their radar today.
Do you have any of these stocks in your portfolio?
Check out the full list of what brokerages recommend, including IndusInd Bank, Maruti Suzuki, Zomato, HDFC Life Insurance, Apollo Hospitals, Macrotech Developers, and other stocks:
IndusInd Bank
Global brokerages are upbeat on IndusInd Bank shares a day after the private lender announced its March quarter earnings. The bank reported a 46 per cent jump in its March quarter net profit at Rs 2,043 crore on a dip in provisions and stronger core income.
Brokerage | Rating | Price Target |
CLSA | Buy | Rs 1,500 |
Morgan Stanley | Overweight | Rs 1,525 |
JP Morgan | Neutral | Rs 1,060 |
Jefferies | Buy | Rs 1,550 |
Goldman Sachs | Buy | Raised to Rs 1,522 from Rs 1,411 |
Citi | Buy | Cut to Rs 1,380 from Rs Rs 1,411 |
Macquarie | Outperform | Rs 1,510 |
Maruti Suzuki
Most brokerages are bullish on Maruti Suzuki India ahead of its fourth-quarter earnings on Wednesday. Citi maintained a ‘buy’ rating, while Macquarie has an ‘outperform’ stance and Nomura gives a 'neutral' call on the stock.
Brokerage | Rating | Price Target |
Citi | Buy | Rs 12,500 |
Macquarie | Outperform | Rs 10,508 |
Nomura | Neutral | Rs 9928 |
Zomato
Citi retains a ‘buy’ call, while Morgan Stanley has an ‘overweight’ call on Zomato – an online food delivery company.
Brokerage | Rating | Price Target |
Citi | Buy | Rs 76 |
Morgan Stanley | Overweight | Cut to Rs 74 from Rs Rs 82 |
Citi in its commentary said, “Both Zomato and Swiggy have introduced monetisation in the dining out the segment. While this appears to be a limited roll-out for now, nevertheless, it is positive for medium-term platform monetization.”
HDFC Life Insurance
Brokerage | Rating | Price Target |
Citi | Buy | Rs 595 |
Morgan Stanley | Overweight | Rs 650 |
Apollo Hospitals
Brokerage | Rating | Price Target |
Goldman Sachs | Buy | Cut to Rs 5,050 from Rs Rs 5,100 |
Nomura | Buy | Rs 5,107 |
Macrotech Developers
Brokerage | Rating | Price Target |
CLSA | Outperform | Cut to Rs 1,048 from Rs 1,083 |
JP Morgan | Neutral | Cut to Rs 1,050 from Rs 1,100 |
Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
(Disclaimer: The views/suggestions/advices expressed here in this article is solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Latest FD Rates: Know what SBI, PNB, Canara Bank, HDFC Bank, ICICI Bank are providing on 1-year, 3-year and 5-year fixed deposits
Sukanya Samriddhi Yojana vs PPF: Rs 1 lakh/year investment for 15 years; which can create larger corpus on maturity?
09:55 AM IST